These Snai2-target genes could represent novel pharmacological targets and/or biomarkers in cancers linked to Snai2 (Perez-Mancera et al, 2005; Bermejo-Rodriguez et al, 2006; Perez-Caro and Sanchez-Garcia, 2006). This evidence concerns the gene SNAI2 and cancer.